Clinical Case Reports (Sep 2022)

A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman

  • Kaishi Otsuka,
  • Takashi Matsuo,
  • Takashi Ishimatsu,
  • Atsuki Fukae,
  • Takuro Hamamoto,
  • Koji Oku,
  • Masahiro Ito

DOI
https://doi.org/10.1002/ccr3.6161
Journal volume & issue
Vol. 10, no. 9
pp. n/a – n/a

Abstract

Read online

Abstract Coronavirus disease 2019 (COVID‐19) vaccination is reportedly safe and effective. The histologic features of post‐COVID‐19 vaccination myocarditis are unknown. We present a case of a 77‐year‐old Japanese woman diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after the second dose of BNT162b2 COVID‐19 vaccine. Steroid pulse therapy was effective.

Keywords